Xuanzhu Biopharmaceutical
2575 · HKEX
Public Market Listing
2575HKEX
Live quotes, historical charts, and market capitalization for Xuanzhu Biopharmaceutical are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(4 total)
4Total Assets
0Approved
2Phase 3 / Filed
2Phase 1–2 / Early
2Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | CDK2/4/6Small molecule | Breast Cancer HR+/HER2- Metastatic Breast Cancer | |
| Phase 3 | ALK / ROS1Small molecule | Non-Small Cell Lung Cancer | |
| Phase 1/2 | ROS1/NTRKSmall molecule | Non-Small Cell Lung Cancer | |
| Phase 1 | AXL inhibitorSmall molecule | Non-Small Cell Lung Cancer |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Regulatory and conference events
(2)
Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.
Recent